FORUS Therapeutics
  • About
    • About FORUS
    • Leadership
    • Values
  • Products
  • Partners
  • Careers
  • News
  • Contact
  • Français
Select Page
New Canadian Pharmaceutical Company Brings Novel Cancer Therapies to Market

New Canadian Pharmaceutical Company Brings Novel Cancer Therapies to Market

Jan 27, 2021

(Toronto, Ont.) January 27, 2021 ­– FORUS Therapeutics launches today, bringing a new pharmaceutical company onto the Canadian landscape. With a highly-experienced and proven team, an FDA-approved product already in its pipeline, and significant financial investment...

Recent Posts

  • US-authorized BESREMi® Now Available
  • FORUS and PharmaEssentia Have Entered Into an Exclusive Licensing Agreement for The Registration and Distribution of BESREMi® for The Treatment of polycythemia vera (PV), in Canada
  • WELCOME, Karen Winkworth
  • WELCOME, Chris Mitton
  • INESSS Recommendation to Deny Reimbursement for Multiple Myeloma Treatment is a Global Outlier

Recent Comments

    Archives

    • March 2025
    • November 2024
    • September 2024
    • April 2024
    • November 2023
    • October 2023
    • September 2023
    • June 2023
    • May 2023
    • April 2023
    • January 2023
    • October 2022
    • September 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • February 2022
    • December 2021
    • September 2021
    • July 2021
    • June 2021
    • January 2021

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Follow

    Privacy   |   Accessibility

    About FORUS
    Leadership
    Values
    Products
    Careers
    Partners
    News
    Contact

    Copyright © 2025 FORUS Therapeutics Inc.
    All rights reserved
    Website Design by Eggbeater Creative.

    Contact Us
    Font Resize
    Accessibility by WAH